RemeGen Rises, Falls Along With Chinese Antibody Ambitions

Discipline, Deals Key?

 
• By Brian Yang
  
Share price falling
RemeGen's stock price hit in apparent reflection of multiple challenges • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia